SLC31A1 and ovarian carcinoma: It is the first time to report that milk-exosome deliver cisplatin into ovarian cancer cells through clathrin-independent endocytosis and macropinocytosis, rather than rely on direct fusion or well-known plasma membrane transporter hCtr1.